Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

ABSTRACT: The aim of this study is to assess the Fecal Microbiota Transplantation (FMT) efficacy in the prevention of allogeneic hematopoietic stem cell transplantation (allo-HSCT) complications and particularly Graft versus Host Disease (GvHD). The hypothesis of this study is that allogeneic FMT may improve outcomes of these patients.

DISEASE(S): Myelodysplastic Syndromes,Hodgkin Lymphoma,Chronic Lymphocytic Leukemia,Acute Leukemia In Remission,Leukemia,Graft Versus Host Disease,Lymphoma, Non-hodgkin,Myeloproliferative Syndrome,Myeloma,Leukemia, Lymphocytic, Chronic, B-cell,Lymphoma

PROVIDER: 2381286 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR